Racial and ethnic differences in COVID-19 outcomes: a call to action.
作者信息
Robinson Philip C, Yazdany Jinoos
机构信息
Faculty of Medicine, University of Queensland, Brisbane, QLD 4006, Australia.
Royal Brisbane & Women's Hospital, Metro North Hospital and Health Service, Brisbane, QLD, Australia.
出版信息
Lancet Rheumatol. 2022 Jul;4(7):e455-e457. doi: 10.1016/S2665-9913(22)00135-7. Epub 2022 Jun 9.
Abstract
摘要
相似文献
1
Racial and ethnic differences in COVID-19 outcomes: a call to action.新冠疫情结果中的种族和民族差异：行动呼吁。
Lancet Rheumatol. 2022 Jul;4(7):e455-e457. doi: 10.1016/S2665-9913(22)00135-7. Epub 2022 Jun 9.
2
Applying the Health Belief Model to Characterize Racial/Ethnic Differences in Digital Conversations Related to Depression Pre- and Mid-COVID-19: Descriptive Analysis.应用健康信念模型来描述新冠疫情前和疫情中期与抑郁症相关的数字对话中的种族/民族差异：描述性分析。
JMIR Form Res. 2022 Jun 20;6(6):e33637. doi: 10.2196/33637.
3
A Call to Action: A Systematic Review Examining the Failure to Include Females and Members of Minoritized Racial/Ethnic Groups in Clinical Trials of Pharmacological Treatments for Alcohol Use Disorder.行动呼吁：系统审查未能在药物治疗酒精使用障碍的临床试验中纳入女性和少数族裔成员
Alcohol Clin Exp Res. 2020 Oct;44(10):1933-1951. doi: 10.1111/acer.14440. Epub 2020 Sep 30.
4
Racial and Ethnic Disparities in COVID-19 Incidence by Age, Sex, and Period Among Persons Aged <25 Years - 16 U.S. Jurisdictions, January 1-December 31, 2020.2020 年 1 月 1 日至 12 月 31 日，年龄<25 岁人群中 COVID-19 发病率的年龄、性别和时期的种族和民族差异-16 个美国司法管辖区。
MMWR Morb Mortal Wkly Rep. 2021 Mar 19;70(11):382-388. doi: 10.15585/mmwr.mm7011e1.
5
Disproportionate Impact of COVID-19 Pandemic on Racial and Ethnic Minorities.**译文**：COVID-19 大流行对少数族裔的不成比例影响。
Am Surg. 2020 Dec;86(12):1615-1622. doi: 10.1177/0003134820973356. Epub 2020 Nov 24.
6
Trends in Racial and Ethnic Disparities in COVID-19 Hospitalizations, by Region - United States, March-December 2020.2020 年 3 月至 12 月美国按地区划分的 COVID-19 住院患者的种族和民族差异趋势。
MMWR Morb Mortal Wkly Rep. 2021 Apr 16;70(15):560-565. doi: 10.15585/mmwr.mm7015e2.
7
Racial and Ethnic Disparities, Kidney Disease, and COVID-19: A Call to Action.种族与民族差异、肾脏疾病和2019冠状病毒病：行动呼吁
Kidney Med. 2020 Sep-Oct;2(5):509-510. doi: 10.1016/j.xkme.2020.07.001. Epub 2020 Jul 21.
8
COVID-19 cases in US counties: roles of racial/ethnic density and residential segregation.美国各县的新冠病毒肺炎病例：种族/族裔密度和居住隔离的作用。
Ethn Health. 2021 Jan;26(1):11-21. doi: 10.1080/13557858.2020.1830036. Epub 2020 Oct 15.
9
Examining U.S. Newspapers' Effects on COVID-19 Infection Rates Among Racial/Ethnic Minorities.审视美国报纸对少数族裔新冠病毒感染率的影响。
Health Equity. 2022 Feb 2;6(1):81-90. doi: 10.1089/heq.2021.0142. eCollection 2022.
10
Racial and Ethnic Inequities in Mortality During Hospitalization for Traumatic Brain Injury: A Call to Action.创伤性脑损伤住院期间死亡率的种族和民族不平等：行动呼吁。
Front Surg. 2021 Jun 2;8:690971. doi: 10.3389/fsurg.2021.690971. eCollection 2021.
引用本文的文献
1
One size doesn't fit all: methodological reflections in conducting community-based behavioural science research to tailor COVID-19 vaccination initiatives for public health priority populations.一刀切不适用：基于社区的行为科学研究方法的反思，以针对公共卫生重点人群调整 COVID-19 疫苗接种计划。
BMC Public Health. 2024 Mar 13;24(1):784. doi: 10.1186/s12889-024-18270-x.
2
Predictors of COVID-19 severity and outcomes in Indian patients with rheumatic diseases: a prospective cohort study.印度风湿性疾病患者新冠病毒病严重程度及预后的预测因素：一项前瞻性队列研究
Rheumatol Adv Pract. 2023 Feb 28;7(1):rkad025. doi: 10.1093/rap/rkad025. eCollection 2023.
3
Preventive medicine in rheumatology: COVID-19 and its lessons for better health outcomes.风湿病学中的预防医学：2019冠状病毒病及其对改善健康结局的启示。
Lancet Rheumatol. 2022 Nov;4(11):e743-e745. doi: 10.1016/S2665-9913(22)00229-6. Epub 2022 Aug 16.
本文引用的文献
1
Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform.与免疫介导的炎症性疾病和免疫调节疗法相关的重症 COVID-19 结局风险：OpenSAFELY 平台的一项全国性队列研究
Lancet Rheumatol. 2022 Jul;4(7):e490-e506. doi: 10.1016/S2665-9913(22)00098-4. Epub 2022 Jun 9.
2
Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative.免疫抑制药物的长期使用与新冠肺炎住院结局：一项使用国家新冠队列协作项目数据的回顾性队列研究
Lancet Rheumatol. 2022 Jan;4(1):e33-e41. doi: 10.1016/S2665-9913(21)00325-8. Epub 2021 Nov 15.
3
What does endemic COVID-19 mean for the future of rituximab?地方性新冠病毒肺炎对利妥昔单抗的未来意味着什么？
Lancet Rheumatol. 2022 Jan;4(1):e3-e5. doi: 10.1016/S2665-9913(21)00362-3. Epub 2021 Nov 15.
4
Risk of COVID-19 in Rheumatoid Arthritis: A National Veterans Affairs Matched Cohort Study in At-Risk Individuals.类风湿关节炎患者感染 COVID-19 的风险：全国退伍军人事务部高危人群匹配队列研究。
Arthritis Rheumatol. 2021 Dec;73(12):2179-2188. doi: 10.1002/art.41800. Epub 2021 Oct 19.
5
COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study.接受利妥昔单抗治疗的炎症性风湿和肌肉骨骼疾病患者的COVID-19结局：一项队列研究。
Lancet Rheumatol. 2021 Jun;3(6):e419-e426. doi: 10.1016/S2665-9913(21)00059-X. Epub 2021 Mar 25.
6
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry.风湿性疾病患者 COVID-19 相关死亡的相关因素：来自 COVID-19 全球风湿病联盟医生报告登记处的结果。
Ann Rheum Dis. 2021 Jul;80(7):930-942. doi: 10.1136/annrheumdis-2020-219498. Epub 2021 Jan 27.
7
COVID-19 Outcomes in Patients With Systemic Autoimmune Rheumatic Diseases Compared to the General Population: A US Multicenter, Comparative Cohort Study.COVID-19 结局在患有系统性自身免疫性风湿病患者与普通人群中的比较：一项美国多中心、对照队列研究。
Arthritis Rheumatol. 2021 Jun;73(6):914-920. doi: 10.1002/art.41619. Epub 2021 May 1.
8
Association of Race and Ethnicity With COVID-19 Outcomes in Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance Physician Registry.种族和民族与风湿性疾病 COVID-19 结局的关联：来自 COVID-19 全球风湿病联盟医师注册处的数据。
Arthritis Rheumatol. 2021 Mar;73(3):374-380. doi: 10.1002/art.41567. Epub 2021 Feb 2.
Zotero 插件